Publications by authors named "Pat Shepherd"

Claim this Profile
S
Second-generation tyrosine kinase inhibitors improve the survival of patients with chronic myeloid leukemia in whom imatinib therapy has failed.
Amr R Ibrahim, Richard E Clark, Tessa L Holyoake, Jenny Byrne, Pat Shepherd

Haematologica· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Restricted access to second generation tyrosine kinase inhibitors in the UK could result in suboptimal treatment for almost half of chronic myeloid leukaemia patients: results from a West of Scotland and Lothian population study.
Paolo Gallipoli, Pat Shepherd, David Irvine, Mark Drummond, Tessa Holyoake

Br J Haematol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Panhypopituitarism secondary to a macroprolactinoma manifesting with pancytopenia: case report and literature review.
George I Holmes, Pat Shepherd, James D Walker

Endocr Pract· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia.
Dragana Milojkovic, Emma Nicholson, Jane F Apperley, Tessa L Holyoake, Pat Shepherd

Haematologica· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete molecular responses are achieved after reduced intensity stem cell transplantation and donor lymphocyte infusion in chronic myeloid leukemia.
Nicholas B Heaney, Mhairi Copland, Karen Stewart, Judith Godden, Anne N Parker, Pat Shepherd

Blood· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of the combination of baseline risk group and cytogenetic response on the survival of patients with chronic myeloid leukemia treated with interferon alpha.
Joerg Hasford, Markus Pfirrmann, Pat Shepherd, Joëlle Guilhot, Rüdiger Hehlmann

Haematologica· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of CML using IFN-alpha: impact on quality of life.
Janis Homewood, Maggie Watson, Sue M Richards, Jim Halsey, Pat C A Shepherd

Hematol J· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival of patients with chronic-phase chronic myeloid leukaemia on imatinib after failure on interferon alfa.
David Marin, Sarah Marktel, Richard Szydlo, John P Klein, Marco Bua, Pat Shepherd

Lancet· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Not so NICE for CML.
John Goldman, Jane Apperley, Richard Clark, Tony Green, Tessa Holyoake, Pat Shepherd

Lancet· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis